HOME › Press Releases › Infusion Pump Market worth 10.2 Billion USD by 2020
Infusion Pump Market worth 10.2 Billion USD by 2020
The report "Infusion Pump Market - by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), by Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), by End User (Hospital, Home Care, Ambulatory Surgery Centers) - Global Forecast to 2020", is poised to reach ~USD 10.2 Billion by 2020.
Browse 240 market tables and 46 figures spread through 267 pages and in-depth TOC on "Infusion Pump Market - by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), by Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), by End User (Hospital, Home Care, Ambulatory Surgery Centers) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
This report studies the Infusion Pumps and Accessories market over the forecast period of 2015 to 2020.
The global infusion pumps and accessories market is expected to reach USD 10.2 Billion by 2020 at a CAGR of 5.8% during the forecast period. Growth in this market is mainly attributed to the increasing prevalence of chronic diseases owing to the rising geriatric population; increasing use of infusion products in home care with favorable reimbursement coverage; and technological improvements in infusion products. However, the stringent product approval process and occurrence of several cases of medication errors associated with infusion pumps (and related product recalls in the recent past) may restrain the growth of the infusion pumps and accessories market during the forecast period. Product innovations focusing on improving the safety features of infusion pumps are at the center of the R&D efforts of leading players in this market.
In this report, the infusion pumps and accessories market is segmented by product, application, and end user. Among infusion pumps & accessories, infusion pump accessories (comprising dedicated and non-dedicated disposables) accounted for the largest share of 68.0% of the market in 2014. This segment includes dedicated disposables for volumetric, syringe, insulin, enteral, ambulatory, patient-controlled analgesia, and implantable infusion pumps. This segment accounted for the largest share—88.1%—of the infusion pump accessories market in 2014.
The infusion pumps segment comprises volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps. Volumetric infusion pumps accounted for the largest share of the global infusion pumps market in 2014. Growth in this market is mainly driven by the increasing demand for volumetric infusion pumps in hospitals, long-term acute care centers, clinics, and ambulatory surgery centers.
On the basis of application, the infusion pumps and accessories market is segmented into chemotherapy, gastroenterology, diabetes, pediatrics, pain management, hematology, and other applications. The chemotherapy/oncology segment accounted for the largest share—34.7%—of the global infusion pumps and accessories market in 2014. This is attributed to the high prevalence of cancer across the globe and need of infusion pumps in the delivery of chemotherapy to such patients. Diabetes and pain management applications offer significant growth opportunities in the infusion pumps market.
The infusion pumps and accessories market, by end user, is segmented into hospitals, home care, ambulatory surgery centers, and others. The hospitals segment accounted for the largest share—54.9%—of the global infusion pumps and accessories market in 2014. This can be largely attributed to the financial capabilities of hospitals to purchase high-priced infusion devices as well as the availability of trained professionals to operate infusion devices.
North America represented the largest regional market in 2014, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Asian countries (particularly China and India) and Latin American countries (particularly Brazil) are expected to offer significant growth opportunities for market players in the forecast period. The high growth in emerging countries is majorly attributed to the increasing prevalence of chronic diseases; growing utilization of ambulatory pumps such as disposable and chemotherapy pumps in the management of chronic diseases; improving healthcare infrastructure; and increasing disposable income of the middle-class population in several Asia-Pacific and Latin American countries.
The major players in the infusion pumps and accessories market are CareFusion Corporation (U.S.), Baxter International, Inc. (U.S.), Hospira, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius SE & CO. KGaA (Germany), Medtronic, Inc. (U.S.), Smiths Medical (U.S.), Terumo Corporation (Japan), Moog, Inc. (U.S.), Roche Holdings Ltd. (Switzerland), and Johnson & Johnson (U.S.). Other players include Pfizer Inc. (U.S.), Novartis (Switzerland), Unomedical A/S (Denmark), Kimberly-Clark Corp (U.S.), DJO Inc. (U.S.), Excelsior Medical Corp. (U.S.), ICU Medical Inc. (U.S.), I-Flow Corporation (U.S.), Insulet Corp. (U.S.), IRadimed Corp (U.S.), LMA International NV (U.S.), Nipro Medical Corp. (U.S.), Summit Medical Group (U.S.), Symbios Medical LLC. (U.S.), Universal Medical Technologies Inc. (U.S.), and Zyno Medical LLC (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India